UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 000-08408 WOODWARD, INC. (Exact name of registrant as specified in its charter) Delaware 36-1984010 (State or other jurisdiction ...

WWD Woodward, Inc. (NASDAQ:WWD) Q1 2023 Earnings Conference Call January 30, 2023 4:30 PM ET Company Participants Dan Provaznik - Director of Investor Relations Chip Blankenship - Chairman and Chief Executive Officer Mark Hartman - Chief Financial Officer Conference Call Participants Robert Spingarn - Melius Research Pete Skibitski - Alembic Global Christopher Glynn - Oppenheimer Matt Akers - Wells Fargo David Strauss - Barclays Sheila Kahyaoglu - Jefferies Gautam Khanna - Cowen Louis Raffetto - Wolfe Resea ...

MS WOODWARD FISCAL YEAR 2023 FIRST QUARTER RESULTS January 30, 2023 Q1 FISCAL YEAR 2023 AGENDA ________ ________ ________ INTRODUCTION Dan Provaznik STRATEGIES & MARKET REVIEW Chip Blankenship FINANCIAL RESULTS & OUTLOOK Mark Hartman 2 | © WOODWARD, INC. PROPRIETARY © WOODWARD, INC. | --- ...

W WOODWARD FOURTH QUARTER AND FISCAL YEAR 2022 RESULTS November 17, 2022 Q4 FISCAL YEAR 2022 AGENDA ________ ________ ________ INTRODUCTION Dan Provaznik IMPRESSIONS & MARKET REVIEW Chip Blankenship FINANCIAL RESULTS & OUTLOOK Mark Hartman 2 | © WOODWARD, INC. PROPRIETARY © WOODWARD, INC. | --- ...

W WOODWARD FISCAL YEAR 2022 THIRD QUARTER RESULTS August 1, 2022 Q3 FY22 AGENDA ________ ________ ________ HIGHLIGHTS Dan Provaznik FIRST IMPRESSIONS & MARKET REVIEW Chip Blankenship FINANCIAL RESULTS & OUTLOOK Mark Hartman 2 | © WOODWARD, INC. PROPRIETARY © WOODWARD, INC. | --- | --- ...

M WOODWARD FISCAL YEAR 2022 SECOND QUARTER RESULTS May 2, 2022 Q2 FY22 AGENDA ________ ________ ________ HIGHLIGHTS Dan Provaznik MARKET REVIEW Tom Gendron FINANCIAL RESULTS & OUTLOOK Mark Hartman 2 | © WOODWARD, INC. PROPRIETARY © WOODWARD, INC. | --- ...

Fiscal Year 2022 First Quarter Results January 31, 2022 Today's Agenda Highlights Market Review Financial Results & Outlook Q&A Dan Provaznik Tom Gendron Mark Hartman 2 | © WOODWARD, INC. PROPRIETARY Cautionary Statement Information in this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, including, but not limited to, statements regarding our business and financial outlook for fiscal 2022, inclu ...

Fiscal Year 2021 Third Quarter Results August 2, 2021 Today's Agenda Highlights Market Review Financial Results & Outlook Q&A Don Guzzardo Tom Gendron Bob Weber 2 | © WOODWARD, INC. PROPRIETARY Cautionary Statement Information in this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements about of the recovery of global economi ...

Fiscal Year 2021 First Quarter Results February 1, 2021 Today's Agenda Highlights Market Review Financial Results & Outlook Q&A Don Guzzardo Tom Gendron Bob Weber 2 | © WOODWARD, INC. PROPRIETARY Cautionary Statement Information in this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, including, but not limited to, statements about the continued and expected or potential effects of the COVID-19 p ...

Fourth Quarter and Fiscal Year 2020 Results November 19, 2020 Today's Agenda Highlights Market Review Financial Results & Outlook Q&A Don Guzzardo Tom Gendron Bob Weber 2 | © WOODWARD, INC. PROPRIETARY Cautionary Statement Information in this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, including, but not limited to, statements about the continued and expected or potential effects of the COVI ...